Abstract:OBJECTIVE:To investigate the clinicopathological characteristics of micro and mini parotid gland tumors and to provide reference for their clinical diagnosis and treatment. METHODS:Patients with parotid gland tumors treated in the Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology from December 2012 to April 2020 were selected. Relevant clinical data of the patients with tumor diameter ≤20 mm detected by preoperative CT were collected to analyze the clinicopathological characteristics and prognosis of micro and mini parotid gland tumors. And the collected data were divided into two groups with diameter 11-20 mm and diameter ≤10 mm according to tumor diameter measured by preoperative CT. The clinicopathological differences between the two groups were statistically analyzed. RESULTS:A total of 2 067 patients with primary epithelial parotid gland tumors were collected, and 685 patients with tumor diameter ≤20 mm were examined by CT, accounting for 33.1%. The ratio of male to female patients with micro and mini parotid gland tumors was 1 ∶1.93, the average age was (45.3±13.8) years (12-83 years), and the median course of disease was 12 months (1 week to 30 years). Among them, 635 cases (92.7%) were benign tumors, 50 cases (7.3%) were malignant tumors, and the ratio of benign to malignant was 12.7 ∶1. The most common benign tumor was pleomorphic adenoma, and the most common malignant tumor was mucoepidermoid carcinoma. The micro and mini parotid gland tumors were divided into 11-20 mm group (n=611) and ≤10 mm group (n=74), the clinical characteristics comparison of the two groups of gender ratio, average age, course of di-sease had no statistical difference (P>0.05). In the 11-20 mm diameter group, the percentage of benign and malignant tumor was 92.8% (567/611) and 7.2% (44/611) respectively, and the ratio of benign to malignant tumors was 12.9 ∶1. In the ≤10 mm diameter group, the percentage of benign and malignant tumor was 91.9% (68/74) and 8.1% (6/74) respectively, and the ratio of benign to malignant tumors was 11.3 ∶1. There was no significant difference between the two groups (P>0.05). Fifty patients with malignant tumor were followed up for the median follow-up period of 39.5 months (1-91 months). Local recurrence occurred in 2 patients with one death. The overall 2-year survival rate was 93.7% and the 5-year survival rate was 89.3%. CONCLUSION:The majority of micro and mini parotid gland tumors was benign lesion. There was a good prognosis for micro and mini parotid gland carcinoma. Early surgical treatment was recommended for micro and mini parotid gland tumors.

The efficacy of clinicopathological and imaging features in differentiating benign from malignant parotid micro- and minitumors: A retrospective analysis

Study on detection of tumor markers in serum in diagnosis of parotid tumor

Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.

[Clinicopathologic Analysis of Micro and Mini Parotid Gland Tumors].

Application of Ultrasound and Contrast-Enhanced Ultrasound to Distinguish Salivary Focal Inflammatory Masses from Malignant Masses: A Retrospective Observational Study

Preoperative CT-based intra- and peri-tumoral radiomic models for differentiating benign and malignant tumors of the parotid gland: a two-center study

A Nomogram Based on Clinical Information, Conventional Ultrasound and Radiomics Improves Prediction of Malignant Parotid Gland Lesions

Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram

Analysis on the CT findings of benign and malignant parotid tumors

Study on the CT Imaging Findings and Differential Value of Benign and Malignant Parotid Tumors

MRI-Based radiomics nomogram for differentiation of benign and malignant lesions of the parotid gland

Differentiating benign and malignant parotid gland tumors using CT images and machine learning algorithms

Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review

Clinical analysis of 14 cases of accessory parotid gland tumors and treatment experience

Diagnostic performance of MRI-based radiomics models using machine learning approaches for the triple classification of parotid tumors

Clinicopathological Features and Possible Prognostic Factors in Parotid Lymphomas

Contrast-Enhanced Ultrasound and Strain Elastography for Differentiating Benign and Malignant Parotid Tumors

Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland

CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors

A retrospective analysis of 350 cases of parotid gland tumors and the value of ultrasound in the diagnosis of benign and malignant parotid gland tumors

Thyroid microcarcimoma